Quantcast

Woman is praised for her VERY amusing comeback after man sent her a nude photo

Woman is praised for her VERY amusing response to a man who sent her a nude picture after tricking him into thinking it had...
More

    Coronavirus Sweden: Authorities to bring in local lockdowns as Covid cases rise

    Swedish authorities to bring in local lockdowns as coronavirus cases rise - after country resisted harsh restrictions and relied on social distancing to halt...

    John Leslie NOT GUILTY of groping woman’s breasts in 2008 

    John Leslie collapses and cries as he is found NOT GUILTY of groping woman's breasts at Christmas party in 2008 by jury after 23...

    Lachie Neale and wife Julie Neale lead the celebrity arrivals at the AFL Brownlow Medal ceremony 

    The Lions Lachie Neale and wife Julie Neale lead the celebrity arrivals at the AFL Brownlow Medal ceremony By Marta Jary For Daily Mail Australia...

    Baywatch star Jeremy Jackson’s homeless ex-wife Loni Willison is seen for first time in 2 years

    Baywatch star Jeremy Jackson's homeless ex-wife Loni Willison is seen for first time in 2 years living on the streets of Venice, CA and...

    Manchester man is first to receive experimental arthritis drug in trial to treat Covid-19 

    Coronavirus patient, 41, becomes first in the UK to receive experimental arthritis drug in trial to treat Covid-19

    • Farhan Hamid, 41, has been in intensive care at Manchester Royal Infirmary
    • Received dose of otilimab – potential arthritis treatment – to see effect on Covid
    • Study trial is being funded by GlaxoSmithKline who aim to recruit 800 patients

    A Manchester man has become the first UK patient to be given an experimental arthritis drug in a clinical trial to treat severe Covid-19.

    Farhan Hamid, 41, is in intensive care at Manchester Royal Infirmary.

    He has received a dose of otilimab – which is under investigation as a potential treatment for rheumatoid arthritis – in hopes that this drug could also ease the effects of Covid-19.

    Mr Hamid is part of the Otilimab in Severe Covid-19 Related Disease (Oscar) study which aims to determine whether the drug can treat the severe lung disease caused by the virus.

    Farhan Hamid, 41, has become the first UK patient to be given an experimental arthritis drug in a clinical trial to treat severe Covid-19 at Manchester Royal Infirmary

    The trial at the Manchester hospital is led by Dr Andy Martin. He said: ‘The patients eligible to take part in this study are those experiencing very severe lung difficulties due to Covid-19 and are receiving oxygen or ventilator support.

    ‘We are conducting this study to see whether otilimab – which is under investigation as a potential treatment for rheumatoid arthritis – could also ease the effect of coronavirus on the lungs, dampening the impact of the virus on the immune system.’

    Oscar is funded by UK-based pharmaceutical giant GlaxoSmithKline, which aims to recruit 800 patients globally for the study. Trials are also under way in the US and results are expected in the first half of 2021.

    He has received a dose of otilimab – which is under investigation as a potential treatment for rheumatoid arthritis – in hopes that this drug could also ease the effects of Covid-19

    He has received a dose of otilimab – which is under investigation as a potential treatment for rheumatoid arthritis – in hopes that this drug could also ease the effects of Covid-19

    GSK has said it is aiming to conduct the study at five hospitals in the UK.

    Those taking part will be allocated into two groups at random, with half receiving a one-hour, single infusion of otilimab, while others get a placebo intravenous therapy, in addition to standard care.

    Dr Tim Felton, a senior lecturer at the University of Manchester and clinical lead for all Covid-19-related studies at Manchester University NHS Foundation Trust, said: ‘The primary end point of this study is that participants are alive and free of lung failure after 28 days – so this research is potentially life-saving.’

    Dr Tim Felton, a senior lecturer at the University of Manchester and clinical lead for all Covid-19-related studies at Manchester University NHS Foundation Trust

    Dr Tim Felton, a senior lecturer at the University of Manchester and clinical lead for all Covid-19-related studies at Manchester University NHS Foundation Trust

    Christopher Corsico, senior vice president development at GSK, said: ‘We are continuing to work hard to find solutions to address the pandemic, including exploring potential treatment options for Covid-19 patients.

    ‘We know that some Covid-19 patients experience an overreaction of their immune system – sometimes referred to as cytokine storm – which can lead to hospitalisation or death.

    ‘We believe that otilimab might be able to help counter or calm this process.’

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest Posts

    The shocking photo that proves you should be washing your ‘clean’ rings MUCH more often

    The disgusting photo that proves you should be washing your 'clean' rings more often - and the simple secret to a sparkling finish in...

    Why Things Are Different This Time

    Hi. Welcome to On Politics, your guide to the day in national politics. I’m Lisa Lerer, your host. Sign up here to get On Politics...

    Cruise Ship Rescues 24 People From Sinking Boat Off Florida Coast

    The Carnival Sensation was sailing in international waters off the Florida coast on Saturday when crew members spotted a crowded 36-foot boat that appeared...

    Finally given hope…by the kindness of strangers

    Finally given hope...by the kindness of strangers: Patients with the rarest diseases are often overlooked by medical research - but now families are fighting...